MARA Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MARA Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $907.09M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $656.38M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $387.51M | Mar 2, 2026 |
| FY2023 | Sep 30, 2023 | $97.85M | May 24, 2024 |
| FY2023 | Jun 30, 2023 | $81.76M | May 24, 2024 |
| FY2023 | Mar 31, 2023 | $51.13M | May 24, 2024 |
| FY2024 | Dec 31, 2022 | $117.75M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $159.16M | May 24, 2024 |
| FY2017 | Dec 31, 2017 | $519.6K | Apr 16, 2018 |
| FY2017 | Dec 31, 2016 | $36.63M | Apr 16, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.70M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $96.52M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $57.70M | Mar 2, 2026 |
| FY2022 | Dec 31, 2022 | $28.42M | Mar 16, 2023 |
| FY2023 | Dec 31, 2021 | $24.22M | May 24, 2024 |
| FY2022 | Dec 31, 2020 | $4.36M | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $1.19M | Mar 10, 2022 |
| FY2019 | Dec 31, 2018 | $1.56M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $519.6K | Mar 25, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Sep 30, 2023 | ($15.33M) | May 24, 2024 |
| FY2023 | Jun 30, 2023 | ($10.74M) | May 24, 2024 |
| FY2023 | Mar 31, 2023 | $22.0K | May 24, 2024 |
| FY2023 | Dec 31, 2022 | ($33.67M) | May 24, 2024 |
| FY2023 | Dec 31, 2021 | $116.77M | May 24, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.31B) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $541.25M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $261.17M | Mar 2, 2026 |
| FY2023 | Sep 30, 2023 | ($390.0K) | May 24, 2024 |
| FY2023 | Jun 30, 2023 | ($8.96M) | May 24, 2024 |
| FY2023 | Mar 31, 2023 | $118.70M | May 24, 2024 |
| FY2022 | Dec 31, 2022 | ($392.73M) | Mar 16, 2023 |
| FY2023 | Dec 31, 2021 | ($29.81M) | May 24, 2024 |
| FY2022 | Dec 31, 2020 | ($10.45M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | ($3.52M) | Mar 10, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.22B) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $306.11M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $220.91M | Mar 2, 2026 |
| FY2023 | Sep 30, 2023 | ($80.16M) | May 24, 2024 |
| FY2023 | Jun 30, 2023 | ($6.07M) | May 24, 2024 |
| FY2023 | Mar 31, 2023 | $122.08M | May 24, 2024 |
| FY2022 | Dec 31, 2022 | ($410.9K) | Mar 16, 2023 |
| FY2023 | Dec 31, 2021 | ($2.99M) | May 24, 2024 |
| FY2022 | Dec 31, 2020 | ($9.82M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | ($4.24M) | Mar 10, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.12M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $13.23M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $2.81M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $98.0K | Mar 3, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($802.73M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($677.02M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($315.65M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($176.48M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($18.96M) | May 24, 2024 |
| FY2022 | Dec 31, 2020 | ($7.77M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | ($3.32M) | Mar 10, 2022 |
| FY2019 | Dec 31, 2018 | ($8.24M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($10.81M) | Mar 25, 2019 |
| FY2017 | Dec 31, 2016 | $10.17M | Apr 16, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $407.07M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $250.83M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $27.61M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $41.11M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $273.85M | May 24, 2024 |
| FY2022 | Dec 31, 2020 | $17.74M | Mar 16, 2023 |
| FY2019 | Dec 31, 2019 | $5.2K | Mar 24, 2020 |
| FY2019 | Dec 31, 2018 | $5.25M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $7.8K | Mar 25, 2019 |
| FY2017 | Dec 31, 2016 | $8.4K | Apr 16, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.29B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $6.80B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.99B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.20B | May 24, 2024 |
| FY2022 | Dec 31, 2021 | $1.44B | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $313.25M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $6.62M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $5.19M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $15.06M | Mar 25, 2019 |
| FY2017 | Dec 31, 2016 | $18.29M | Apr 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $765.22M | Mar 10, 2022 |
| FY2021 | Dec 31, 2020 | $1.51M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $2.97M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $2.27M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $7.67M | Mar 25, 2019 |
| FY2017 | Dec 31, 2016 | $27.58M | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $34.55M | Apr 5, 2017 |
| FY2015 | Dec 31, 2014 | $36.53M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $785.6K | Mar 26, 2015 |
| FY2012 | Dec 31, 2012 | $87.8K | Mar 28, 2013 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.47B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $4.13B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.62B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $385.94M | May 24, 2024 |
| FY2022 | Dec 31, 2021 | $682.10M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $311.74M | Mar 10, 2022 |
| FY2021 | Dec 31, 2019 | $3.65M | Mar 10, 2022 |
| FY2021 | Mar 31, 2019 | $2.16M | Mar 10, 2022 |
| FY2021 | Dec 31, 2018 | $2.92M | Mar 10, 2022 |
| FY2019 | Dec 31, 2017 | $7.39M | Mar 24, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $82.75M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Mar 3, 2025 |
| FY2017 | Dec 31, 2016 | $222.8K | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $4.48M | Apr 5, 2017 |
| FY2015 | Dec 31, 2014 | $4.89M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $2.14M | Mar 26, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.34B) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($26.39M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($567.64M) | Mar 3, 2025 |
| FY2023 | Jan 1, 2023 | $11.50M | May 24, 2024 |
| FY2023 | Dec 31, 2022 | ($840.34M) | May 24, 2024 |
| FY2023 | Dec 31, 2021 | ($146.32M) | May 24, 2024 |
| FY2021 | Dec 31, 2020 | ($116.06M) | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | ($105.61M) | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | ($102.09M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($89.28M) | Mar 25, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $547.13M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $391.77M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $357.31M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $103.71M | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | $268.56M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $141.32M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $693.0K | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $2.55M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $14.95M | Mar 25, 2019 |
| FY2018 | Dec 31, 2016 | $5.00M | Mar 25, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.60B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $2.45B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $325.65M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $782.17M | May 24, 2024 |
| FY2022 | Dec 31, 2021 | $728.41M | Mar 16, 2023 |
| FY2020 | Dec 31, 2019 | $999.1K | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $999.1K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $1.76M | Mar 25, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 2, 2026 |
| FY2023 | Sep 30, 2023 | 0 | May 24, 2024 |
| FY2023 | Jun 30, 2023 | 0 | May 24, 2024 |
| FY2023 | Mar 31, 2023 | 0 | May 24, 2024 |
| FY2022 | Dec 31, 2022 | (3) | Mar 16, 2023 |
| FY2023 | Dec 31, 2021 | 0 | May 24, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 10, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 2, 2026 |
| FY2023 | Sep 30, 2023 | 0 | May 24, 2024 |
| FY2023 | Jun 30, 2023 | 0 | May 24, 2024 |
| FY2023 | Mar 31, 2023 | 0 | May 24, 2024 |
| FY2024 | Dec 31, 2022 | (6) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 0 | May 24, 2024 |
| FY2021 | Dec 31, 2020 | 0 | Mar 10, 2022 |
| FY2021 | Dec 31, 2019 | 0 | Mar 10, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 379.46M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 340.26M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 242.83M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | 145.57M | May 24, 2024 |
| FY2022 | Dec 31, 2021 | 102.73M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 81.97M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | 8.46M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | 6.38M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | 12.48M | Mar 25, 2019 |
| FY2017 | Dec 31, 2016 | 4.64M | Apr 16, 2018 |